Sage Journals: Discover world-class research

Retricted access

Review article

First published 2011-9

Alternative dosing schedules and administration updates for Ixabepilone

Ellen Kossoff

Journal of Oncology Pharmacy Practice

Retricted access

Article commentary

First published 2019-6

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Mário L de Lemos, Carrie Kung, Sally Waignein

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 1985-4

Doxorubicin: Alteration of Dose Scheduling as a Means of Reducing Cardiotoxicity

Bert L. Lum, Jennifer M. Svec, Frank M. Torti

Annals of Pharmacotherapy

Retricted access

Research article

First published 1990-3

Phase I Trial and Biochemical Evaluation of Tiazofurin Administered on a Weekly Schedule

Teresa J. Melink, Gisele Sarosy, Axel-R. Hanauske [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Review article

First published 2012-6

Dexamethasone premedication for prophylaxis of taxane toxicities: Can the doses be reduced when paclitaxel or docetaxel are given weekly?

Joanna R Schwartz

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2003-12

Overcoming Recurrent Cutaneous Reactions from Imatinib Using Once-Weekly Dosing

Tawee Tanvetyanon, Sucha Nand

Annals of Pharmacotherapy

Retricted access

Research article

First published 1963-2

Dose-Response Relationship in Aminonucleoside Nephrosis. ∗

Carl S. Alexander, Vincent R. Hunt, Herbert T. Nagasawa

Experimental Biology and Medicine

Retricted access

Research article

First published 1998-11

Increasing Doses of 5-Fluorouracil and High-Dose Folinic ACID in the Treatment of Metastatic Colorectal Cancer

Maurizio Meregalli, Giancarlo Martignoni, Luciano Frontini [...]

Tumori Journal

Retricted access

Research article

First published 1974-1

Bleomycin alone and in Combination with Methotrexate in the Treatment of Carcinoma of the Esophagus.

Gabriele Tancini, Emilio Bajetta, Gianni Bonadonna

Tumori Journal

Retricted access

Research article

First published 1987-2

Phase II Trial of Weekly 4-EPI-Doxorubicin (Epirubicin) in Squamous Cell Carcinoma of the Head and Neck

Oscar Bertetto, Vincenzo Dongiovanni, Mario Clerico [...]

Tumori Journal

Search results